Litigation Details for Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc (N.D. Tex. 2016)
✉ Email this page to a colleague
Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc (N.D. Tex. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-07-29 |
Court | District Court, N.D. Texas | Date Terminated | 2017-05-24 |
Cause | 35:271 Patent Infringement | Assigned To | James E. Kinkeade |
Jury Demand | Plaintiff | Referred To | |
Parties | TARO PHARMACEUTICALS INC | ||
Patents | 8,445,543; 8,785,420; 8,809,305 | ||
Attorneys | Laurel Kilgour | ||
Firms | Munck Wilson Mandala LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc
Details for Galderma Laboratories LP v. Taro Pharmaceuticals USA Inc (N.D. Tex. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-11-27 | 32 | infringement of U.S. Patent Nos. 8,445,543 (the “’543 Patent”), 8,785,420 (the “’420 Patent”), and 8,809,305…8,809,305 (the “’305 Patent”), collectively “the patents-in-suit.” Generally, the patents-in-suit relate to…asserted patents, which are purportedly owned by Galderma R&D. Without an exclusive patent license… patents-in-suit, and any foreign counterparts or priority applications to the patents-in- … patents-in-suit; • Plaintiffs’ theories regarding alleged infringement of the patents-in-suit | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |